Biomimetic PLGA-based nanocomplexes for improved tumor penetration to enhance chemo-photodynamic therapy against metastasis of TNBC
Source abstract
Abstract
The combination of chemo-photodynamic therapy has become a promising strategy for cancer by overcoming the limitations of chemotherapy. However, hypoxic microenvironment, poor drug penetration, and metastatic malignant tumors still limited the therapeutic efficacy of this strategy on triple-negative breast cancer (TNBC). Hence, we developed a combinational nanosystem for efficient TNBC therapy by programming tumor microenvironment and improving drug penetration ability. First, a hybrid membrane (HM) camouflaged poly lactic-co-glycolic acid (PLGA) nanosystem was developed for tumor-targeted delivery of capsaicin (Cap) to improve the tumor hypoxic microenvironment via dilating tumor blood vessels with oxygenation and promote the accumulation of nano-drugs in the tumor ([email protected] NPs). After administration of [email protected] NPs, the sequential administration of PLGA co-loaded with Gamabufotalin (CS-6) and photosensitizer Chlorin e6 (Ce6) significantly penetrate into tumor core regions ([email protected]&CS-6 NPs). Our results demonstrated that the sequential administration strategy not only effectively inhibits tumor growth, but also significantly inhibits the metastasis of primary TNBC by reducing the expression of hypoxia-inducible factor 1-alpha (HIF-1α), cyclooxygenase-2 (COX-2), and matrix metalloproteinase-9 (MMP-9) in tumor tissues. The study proved a high efficiency of the sequential treatment strategy by combining the vasodilator of capsaicin and tumor-infiltrating biomimetic nano-drugs for TNBC therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns10.1007/s10549-020-05727-x ↗
2. Metastatic and triple-negative breast cancer: challenges and treatment options10.1007/s13346-018-0551-3 ↗
3. Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy10.1186/s12967-018-1679-0 ↗
4. Primary tumor location predicts the site of local relapse after nipple–areola complex (NAC) sparing mastectomy10.1007/s10549-017-4312-7 ↗
5. The prognostic analysis of clinical breast cancer subtypes among patients with liver metastases from breast cancer10.1007/s10147-011-0336-x ↗
6. High interstitial fluid pressure—an obstacle in cancer therapy10.1038/nrc1456 ↗
7. Rational design of nanoparticles with deep tumor penetration for effective treatment of tumor metastasis
8. Strategies to improve tumor penetration of nanomedicines through nanoparticle design10.1002/wnan.1519 ↗
9. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
10. Self-propelled gemini-like LMWH-scaffold nanodrugs for overall tumor microenvironment manipulation via macrophage reprogramming and vessel normalization10.1021/acs.nanolett.9b04024 ↗
11. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension10.1016/j.cmet.2010.05.015 ↗
12. Nanoparticles of chlorin dimer with enhanced absorbance for photoacoustic imaging and phototherapy10.1002/adfm.201706507 ↗
13. Nanotechnology for multimodal synergistic cancer therapy10.1021/acs.chemrev.7b00258 ↗
14. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy10.1039/C6CS00271D ↗
15. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation10.1073/pnas.1113483108 ↗
16. Prevention of distant lung metastasis after photodynamic therapy application in a breast cancer tumor model10.1166/jbn.2016.2208 ↗
17. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment, Lasers in Surgery and Medicine10.1002/lsm.20339 ↗
18. Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells10.1186/1476-4598-13-203 ↗
19. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition10.1016/j.actbio.2020.06.025 ↗
20. Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer10.18632/oncotarget.10388 ↗
21. Erythrocyte-cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma10.1021/acsnano.7b08355 ↗
22. Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance10.1002/smll.201502388 ↗
23. RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer10.1016/j.biomaterials.2019.119301 ↗
24. Hybrid-cell membrane-coated nanocomplex-loaded chikusetsusaponin IVa methyl ester for a combinational therapy against breast cancer assisted by Ce610.1039/D0BM02211J ↗
25. A novel theranostic nanoplatform based on Pd@ Pt-PEG-Ce6 for enhanced photodynamic therapy by modulating tumor hypoxia microenvironment10.1002/adfm.201706310 ↗
26. Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor10.1038/s41467-019-14199-7 ↗
27. Deep tumor penetrating bioparticulates inspired burst intracellular drug release for precision chemo-phototherapy
28. Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy10.1038/s41565-019-0485-z ↗
29. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size10.1038/nnano.2011.166 ↗
30. Asymmetric silica nanoparticles with tunable head-tail structures enhance hemocompatibility and maturation of immune cells10.1021/jacs.6b12622 ↗
31. Cell membrane-covered nanoparticles as biomaterials10.1093/nsr/nwz037 ↗
32. Metal-based nanostructures/PLGA nanocomposites: antimicrobial activity, cytotoxicity, and their biomedical applications10.1021/acsami.9b19435 ↗
33. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics10.1038/s41565-021-00858-8 ↗
34. Penetration and uptake of nanoparticles in 3D tumor spheroids10.1021/acs.bioconjchem.9b00136 ↗
35. Size-transformable hyaluronan stacked self-assembling peptide nanoparticles for improved transcellular tumor penetration and photo-chemo combination therapy10.1021/acsnano.9b08434 ↗
36. Breast cancer as a systemic disease: a view of metastasis10.1111/joim.12084 ↗
37. Overcoming the Achilles' heel of photodynamic therapy10.1039/C6CS00616G ↗
38. Perfluorocarbon@Porphyrin nanoparticles for tumor hypoxia relief to enhance photodynamic therapy against liver metastasis of colon cancer10.1021/acsnano.0c05617 ↗
39. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma10.1007/s10549-010-1240-1 ↗
40. Vasodilator hydralazine promotes nanoparticle penetration in advanced desmoplastic tumors
41. Tumor oxygenation and hypoxia inducible factor-1 functional inhibition via a reactive oxygen species responsive nanoplatform for enhancing radiation therapy and abscopal effects10.1021/acsnano.8b03590 ↗
42. A pH-sensitive nanomedicine incorporating catalase gene and photosensitizer augments photodynamic therapy and activates antitumor immunity10.1016/j.nantod.2022.101390 ↗
43. Safety of nanoparticles in medicine10.2174/1389450115666140804124808 ↗